RAPT Therapeutics (RAPT) EPS (Basic) (2020 - 2023)
Historic EPS (Basic) for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to -$0.87.
- Therapeutics' EPS (Basic) fell 3329.56% to -$0.87 in Q4 2023 from the same period last year, while for Sep 2024 it was -$0.85, marking a year-over-year increase of 7230.94%. This contributed to the annual value of -$3.31 for FY2023, which is 2845.9% down from last year.
- Latest data reveals that Therapeutics reported EPS (Basic) of -$0.87 as of Q4 2023, which was down 3329.56% from -$0.88 recorded in Q3 2023.
- In the past 5 years, Therapeutics' EPS (Basic) ranged from a high of -$0.51 in Q2 2020 and a low of -$0.88 during Q3 2023
- Moreover, its 4-year median value for EPS (Basic) was -$0.63 (2021), whereas its average is -$0.66.
- Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 158.73% in 2022, then plummeted by 4036.09% in 2023.
- Quarter analysis of 4 years shows Therapeutics' EPS (Basic) stood at -$0.52 in 2020, then fell by 17.31% to -$0.61 in 2021, then decreased by 6.56% to -$0.65 in 2022, then plummeted by 33.3% to -$0.87 in 2023.
- Its last three reported values are -$0.87 in Q4 2023, -$0.88 for Q3 2023, and -$0.74 during Q2 2023.